Intriguingly, BDNF levels are also reduced in the brains of AD patients [98], and BDNF has proven to be beneficial both in AD [158] and HD models [64], likely by attenuating extrasynaptic NMDAR signaling [93] and promoting CaMKII autophosphorylation [158]. The gene discussed is CAMK2G; the disease is Huntington disease.